The first Russian experience of sildenafil application in patients with idiopathic pulmonary hypertension
Over the last decade, the interest in the treatment of idiopathic pulmonary hypertension (IPAH) has greatly increased because of the development and implementation of innovative therapeutic approaches. One of the modern drug groups for the treatment of pulmonary arterial hypertension are phosphodies...
Main Authors: | Z Kh Dadacheva, A A Belevskaya, M A Saidova, N M Danilov, T V Martyniuk, I E Chazova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2015-09-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | https://syst-hypertension.ru/2075-082X/article/viewFile/29107/pdf |
Similar Items
-
Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension
by: I N Zavyrylina, et al.
Published: (2015-06-01) -
Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
by: Anne M Keogh, et al.
Published: (2008-10-01) -
Sildenafil in Infants and Children
by: Larisa Simonca, et al.
Published: (2017-07-01) -
One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease
by: A.C. Barreto, et al.
Published: (2005-02-01) -
Pharmacological test with sildenafil at pulmonary hypertension assessing in children with congenital heart diseases
by: O. S. Yanulevich, et al.
Published: (2010-10-01)